Overview

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
To assess the effectiveness and safety of utidelone injection in patients with advanced or metastatic colorectal cancer (CRC) as a phase II trial
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Biostar Technologies, Ltd
Collaborator:
Chengdu Biostar Pharmaceuticals, Ltd